Late left ventricular myocardial remodeling after pulmonary artery banding for end-stage dilated cardiomyopathy in infants: an imaging study

Ponzoni, Matteo; Zanella, Luca; Reffo, Elena; Cavaliere, Annachiara; Pozza, Alice; Castaldi, Biagio; Salvo, Giovanni Di; Vida, Vladimiro L.; Padalino, Massimo A.

doi:10.1016/j.ijcard.2023.05.040

International Journal of Cardiology

2023

DOI: 10.1016/j.ijcard.2023.05.040

|View full text |Cite

Late left ventricular myocardial remodeling after pulmonary artery banding for end-stage dilated cardiomyopathy in infants: an imaging study

Matteo Ponzoni¹,

Luca Zanella²,

Elena Reffo³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent multicenter studies have documented LV functional recovery in 29% to 56% of treated patients, suggesting the potential for PAB to positively alter the natural course of DCM. 4 Imaging studies have shown that PAB can promote progressive LV remodeling and sustained contractile recovery for up to 18 months. 4 …”

mentioning

confidence: 99%

See 1 more Smart Citation

Innovative Multilumen Stent System for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

Tocchi,

Amin,

Vogt

et al. 2023

JACC: Basic to Translational Science

View full text Add to dashboard Cite

mentioning

confidence: 99%

“… 4 Imaging studies have shown that PAB can promote progressive LV remodeling and sustained contractile recovery for up to 18 months. 4 …”

mentioning

confidence: 99%

Innovative Multilumen Stent System for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

Tocchi,

Amin,

Vogt

et al. 2023

JACC: Basic to Translational Science

View full text Add to dashboard Cite

Transcatheter Pulmonary Flow Restrictors: Current Trends and Future Perspectives

Malakan Rad,

Hijazi

2024

Cathet Cardio Intervent

View full text Add to dashboard Cite

BackgroundTranscatheter Pulmonary Flow Restrictors (TPFRs) represent a significant advancement in managing pulmonary blood flow for congenital heart disease patients. However, there is a paucity of comprehensive studies addressing the diversity of these devices and identifying their critical features.AimsThis review aims to consolidate the existing knowledge on TPFRs, pinpoint crucial design and development aspects, identify gaps in current practices, and spotlight directions for future research and advancement.MethodsAn exhaustive search was conducted across multiple databases, using specific search terms related to transcatheter and percutaneous pulmonary artery banding.ResultsBetween 2005 and 2024, 82 patients were reported to have received TPFR implants, including fenestrated atrial septal defect occluders, diabolo‐shaped stents, and MVP™ Micro Vascular Plug with polytetrafluoroethylene (PTFE) membranes partially removed. Microvascular plugs were the most commonly used and the most successful devices. However, the primary complications and challenges associated with MVPs included pulmonary overflow, unprotected flow to the right upper lobe, difficulty in creating an appropriately sized fenestration, the need for device replacement due to incorrect sizing, distal migration into the right pulmonary artery, left pulmonary artery stenosis, partial device collapse, thrombosis, jailing of the right upper lobe, potential injury to the pulmonary arterial wall, as well as device fracture and infection. TPFRs can be categorized based on the duration they are designed to remain within the pulmonary artery. Strategies should be devised to enable the device's easy removal without harming the pulmonary arterial wall while also preventing embolization. The ideal device should minimize migration, embolization, thrombosis, inflammation, and endothelialization risks. It should also prevent peri‐device flow and adapt to the growth of the pulmonary artery, ensuring long‐term efficacy and safety.ConclusionThe long‐term outcomes and the potential for employing biodegradable and smart biomaterials remain areas for further investigation. Successful development of these devices requires a collaborative effort among biomaterial engineers, device developers, and interventional cardiologists.

show abstract

Revived Role of Pulmonary Artery Band in Management of Heart Failure in Pediatric Dilated Cardiomyopathy

Wang

2024

Pediatr Cardiol

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Late left ventricular myocardial remodeling after pulmonary artery banding for end-stage dilated cardiomyopathy in infants: an imaging study

Cited by 4 publications

References 27 publications

Innovative Multilumen Stent System for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

Innovative Multilumen Stent System for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

Transcatheter Pulmonary Flow Restrictors: Current Trends and Future Perspectives

Revived Role of Pulmonary Artery Band in Management of Heart Failure in Pediatric Dilated Cardiomyopathy

Contact Info

Product

Resources

About